Endorsed resource – Predict Prostate
The University of Cambridge Academic Urology Group has produced a decision aid that supports recommendations in the NICE guideline on prostate cancer. It also supports statements 1 and 2 in the NICE quality standard on prostate cancer.
This tool is for comparing the outcomes of conservative management and radical treatment, in men with non-metastatic prostate cancer.
Endorsed resources are complementary to NICE guidance and are not produced by NICE. This resource has been developed by The University of Cambridge Academic Urology Group, and is not maintained by NICE. NICE has not made any judgement about the quality and usability of the resource and has not tested the decision algorithms embedded in it. In the event of any issues or errors, please contact The University of Cambridge Academic Urology Group.
This page was last updated: 22 August 2019